Respiratory therapeutics.
Treatment of small animal respiratory diseases tends to target bronchodilators. Although this is not inappropriate, recent advances in the understanding of respiratory diseases have underscored the importance of inflammatory mediators in the pathophysiology of respiratory diseases. Drug therapy of the respiratory tract in small animals is most successful when it is based on a knowledge of normal physiology and disease pathophysiology of respiratory tract diseases.
Boothe
D M
DM
Department of Veterinary Physiology and Pharmacology, Texas A&M University College of Veterinary Medicine, College Station.
McKiernan
B C
BC
D000818:Animals; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000996:Antitussive Agents / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002371:Cat Diseases / Q000188:drug therapy* / Q000503:physiopathology; D002415:Cats; D004283:Dog Diseases / Q000188:drug therapy* / Q000503:physiopathology; D004285:Dogs; D005938:Glucocorticoids / Q000627:therapeutic use; D012140:Respiratory Tract Diseases / Q000188:drug therapy / Q000503:physiopathology / Q000662:veterinary*
D000890:Anti-Infective Agents; D000996:Antitussive Agents; D001993:Bronchodilator Agents; D005938:Glucocorticoids